ID   ANO4_HUMAN              Reviewed;         955 AA.
AC   Q32M45; Q8NAJ0; Q8NB39; Q8NB53;
DT   29-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   06-DEC-2005, sequence version 1.
DT   28-JUN-2023, entry version 136.
DE   RecName: Full=Anoctamin-4;
DE   AltName: Full=Transmembrane protein 16D;
GN   Name=ANO4; Synonyms=TMEM16D;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Brain, and Prostate;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   IDENTIFICATION.
RX   PubMed=12739008;
RA   Katoh M., Katoh M.;
RT   "FLJ10261 gene, located within the CCND1-EMS1 locus on human chromosome
RT   11q13, encodes the eight-transmembrane protein homologous to C12orf3,
RT   C11orf25 and FLJ34272 gene products.";
RL   Int. J. Oncol. 22:1375-1381(2003).
RN   [4]
RP   REVIEW.
RX   PubMed=21642943; DOI=10.1038/aps.2011.48;
RA   Duran C., Hartzell H.C.;
RT   "Physiological roles and diseases of Tmem16/Anoctamin proteins: are they
RT   all chloride channels?";
RL   Acta Pharmacol. Sin. 32:685-692(2011).
RN   [5]
RP   REVIEW.
RX   PubMed=21607626; DOI=10.1007/s00424-011-0975-9;
RA   Kunzelmann K., Tian Y., Martins J.R., Faria D., Kongsuphol P.,
RA   Ousingsawat J., Thevenod F., Roussa E., Rock J., Schreiber R.;
RT   "Anoctamins.";
RL   Pflugers Arch. 462:195-208(2011).
RN   [6]
RP   REVIEW.
RX   PubMed=22302790; DOI=10.1113/expphysiol.2011.058214;
RA   Winpenny J.P., Gray M.A.;
RT   "The anoctamin (TMEM16) gene family: calcium-activated chloride channels
RT   come of age.";
RL   Exp. Physiol. 97:175-176(2012).
RN   [7]
RP   SUBCELLULAR LOCATION.
RX   PubMed=22946059; DOI=10.1242/jcs.109553;
RA   Tian Y., Schreiber R., Kunzelmann K.;
RT   "Anoctamins are a family of Ca2+ activated Cl- channels.";
RL   J. Cell Sci. 125:4991-4998(2012).
CC   -!- FUNCTION: Has calcium-dependent phospholipid scramblase activity;
CC       scrambles phosphatidylserine, phosphatidylcholine and
CC       galactosylceramide (By similarity). Does not exhibit calcium-activated
CC       chloride channel (CaCC) activity (By similarity).
CC       {ECO:0000250|UniProtKB:Q8C5H1}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phospho-L-serine(in) = a 1,2-diacyl-
CC         sn-glycero-3-phospho-L-serine(out); Xref=Rhea:RHEA:38663,
CC         ChEBI:CHEBI:57262; Evidence={ECO:0000250|UniProtKB:Q8C5H1};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38664;
CC         Evidence={ECO:0000250|UniProtKB:Q8C5H1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a beta-D-galactosyl-(1<->1')-N-acylsphing-4-enine(out) = a
CC         beta-D-galactosyl-(1<->1')-N-acylsphing-4-enine(in);
CC         Xref=Rhea:RHEA:38899, ChEBI:CHEBI:18390;
CC         Evidence={ECO:0000250|UniProtKB:Q8C5H1};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38900;
CC         Evidence={ECO:0000250|UniProtKB:Q8C5H1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphocholine(in) = a 1,2-diacyl-
CC         sn-glycero-3-phosphocholine(out); Xref=Rhea:RHEA:38571,
CC         ChEBI:CHEBI:57643; Evidence={ECO:0000250|UniProtKB:Q8C5H1};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:38573;
CC         Evidence={ECO:0000250|UniProtKB:Q8C5H1};
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:22946059};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:22946059}. Note=Shows
CC       an intracellular localization. {ECO:0000250|UniProtKB:Q8C5H1}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q32M45-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q32M45-2; Sequence=VSP_025742;
CC       Name=3;
CC         IsoId=Q32M45-3; Sequence=VSP_025741, VSP_025743;
CC   -!- MISCELLANEOUS: The term 'anoctamin' was coined because these channels
CC       are anion selective and have eight (OCT) transmembrane segments. There
CC       is some dissatisfaction in the field with the Ano nomenclature because
CC       it is not certain that all the members of this family are anion
CC       channels or have the 8-transmembrane topology.
CC   -!- SIMILARITY: Belongs to the anoctamin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC03688.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK091540; BAC03688.1; ALT_INIT; mRNA.
DR   EMBL; AK091591; BAC03704.1; -; mRNA.
DR   EMBL; AK092596; BAC03924.1; -; mRNA.
DR   EMBL; BC109308; AAI09309.1; -; mRNA.
DR   CCDS; CCDS31884.1; -. [Q32M45-2]
DR   CCDS; CCDS66445.1; -. [Q32M45-1]
DR   RefSeq; NP_001273544.1; NM_001286615.1. [Q32M45-1]
DR   RefSeq; NP_001273545.1; NM_001286616.1. [Q32M45-1]
DR   RefSeq; NP_849148.2; NM_178826.3. [Q32M45-2]
DR   RefSeq; XP_011536216.1; XM_011537914.2.
DR   RefSeq; XP_016874297.1; XM_017018808.1.
DR   RefSeq; XP_016874298.1; XM_017018809.1.
DR   RefSeq; XP_016874299.1; XM_017018810.1.
DR   AlphaFoldDB; Q32M45; -.
DR   SMR; Q32M45; -.
DR   BioGRID; 125740; 19.
DR   IntAct; Q32M45; 2.
DR   STRING; 9606.ENSP00000376703; -.
DR   TCDB; 1.A.17.1.29; the calcium-dependent chloride channel (ca-clc) family.
DR   GlyCosmos; Q32M45; 4 sites, No reported glycans.
DR   GlyGen; Q32M45; 4 sites.
DR   iPTMnet; Q32M45; -.
DR   PhosphoSitePlus; Q32M45; -.
DR   BioMuta; ANO4; -.
DR   DMDM; 121942141; -.
DR   jPOST; Q32M45; -.
DR   MassIVE; Q32M45; -.
DR   PaxDb; Q32M45; -.
DR   PeptideAtlas; Q32M45; -.
DR   ProteomicsDB; 61589; -. [Q32M45-1]
DR   ProteomicsDB; 61590; -. [Q32M45-2]
DR   ProteomicsDB; 61591; -. [Q32M45-3]
DR   Antibodypedia; 66428; 97 antibodies from 14 providers.
DR   DNASU; 121601; -.
DR   Ensembl; ENST00000392977.8; ENSP00000376703.3; ENSG00000151572.18. [Q32M45-1]
DR   Ensembl; ENST00000392979.7; ENSP00000376705.3; ENSG00000151572.18. [Q32M45-2]
DR   Ensembl; ENST00000570509.4; ENSP00000471431.2; ENSG00000262139.9.
DR   Ensembl; ENST00000573650.8; ENSP00000469449.2; ENSG00000262139.9.
DR   Ensembl; ENST00000575847.8; ENSP00000470039.2; ENSG00000262139.9.
DR   GeneID; 121601; -.
DR   KEGG; hsa:121601; -.
DR   MANE-Select; ENST00000392977.8; ENSP00000376703.3; NM_001286615.2; NP_001273544.1.
DR   UCSC; uc001thw.3; human. [Q32M45-1]
DR   AGR; HGNC:23837; -.
DR   CTD; 121601; -.
DR   DisGeNET; 121601; -.
DR   GeneCards; ANO4; -.
DR   HGNC; HGNC:23837; ANO4.
DR   HPA; ENSG00000151572; Tissue enhanced (adrenal gland, brain, cervix, ovary, seminal vesicle).
DR   MIM; 610111; gene.
DR   neXtProt; NX_Q32M45; -.
DR   OpenTargets; ENSG00000151572; -.
DR   PharmGKB; PA164715582; -.
DR   VEuPathDB; HostDB:ENSG00000151572; -.
DR   eggNOG; KOG2514; Eukaryota.
DR   GeneTree; ENSGT00940000158600; -.
DR   HOGENOM; CLU_006685_1_3_1; -.
DR   InParanoid; Q32M45; -.
DR   OMA; XFIIHNK; -.
DR   OrthoDB; 534027at2759; -.
DR   PhylomeDB; Q32M45; -.
DR   TreeFam; TF314265; -.
DR   PathwayCommons; Q32M45; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   Reactome; R-HSA-9733458; Induction of Cell-Cell Fusion.
DR   SignaLink; Q32M45; -.
DR   BioGRID-ORCS; 121601; 15 hits in 1140 CRISPR screens.
DR   ChiTaRS; ANO4; human.
DR   GenomeRNAi; 121601; -.
DR   Pharos; Q32M45; Tbio.
DR   PRO; PR:Q32M45; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q32M45; protein.
DR   Bgee; ENSG00000151572; Expressed in corpus callosum and 92 other tissues.
DR   ExpressionAtlas; Q32M45; baseline and differential.
DR   Genevisible; Q32M45; HS.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005229; F:intracellular calcium activated chloride channel activity; IDA:UniProtKB.
DR   GO; GO:0017128; F:phospholipid scramblase activity; IEA:Ensembl.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   GO; GO:0061591; P:calcium activated galactosylceramide scrambling; IEA:Ensembl.
DR   GO; GO:0061590; P:calcium activated phosphatidylcholine scrambling; IEA:Ensembl.
DR   GO; GO:0061589; P:calcium activated phosphatidylserine scrambling; IEA:Ensembl.
DR   GO; GO:1902476; P:chloride transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006821; P:chloride transport; IDA:UniProtKB.
DR   GO; GO:0051649; P:establishment of localization in cell; IEA:Ensembl.
DR   GO; GO:0034220; P:monoatomic ion transmembrane transport; TAS:Reactome.
DR   InterPro; IPR032394; Anoct_dimer.
DR   InterPro; IPR007632; Anoctamin.
DR   PANTHER; PTHR12308; ANOCTAMIN; 1.
DR   PANTHER; PTHR12308:SF28; ANOCTAMIN-4; 1.
DR   Pfam; PF16178; Anoct_dimer; 1.
DR   Pfam; PF04547; Anoctamin; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell membrane; Glycoprotein; Lipid transport;
KW   Membrane; Reference proteome; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN           1..955
FT                   /note="Anoctamin-4"
FT                   /id="PRO_0000288650"
FT   TOPO_DOM        1..352
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        353..373
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        374..424
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        425..445
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        446..505
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        506..526
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        527..547
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        548..568
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        569..595
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        596..616
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        617..715
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        716..736
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        737..768
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        769..789
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        790..885
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        886..906
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        907..955
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   REGION          72..100
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        83
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        105
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        257
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        288
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..433
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_025741"
FT   VAR_SEQ         19..54
FT                   /note="EGGVDLQGYQLDMQILPDGPKSDVDFSEILNAIQEM -> V (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_025742"
FT   VAR_SEQ         466..512
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_025743"
FT   VARIANT         115
FT                   /note="G -> A (in dbSNP:rs34162417)"
FT                   /id="VAR_032453"
FT   CONFLICT        209
FT                   /note="F -> L (in Ref. 1; BAC03704)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   955 AA;  111462 MW;  9A9348C61A4F20AF CRC64;
     MEASSSGITN GKTKVFHPEG GVDLQGYQLD MQILPDGPKS DVDFSEILNA IQEMAKDVNI
     LFDELEAVSS PCKDDDSLLH PGNLTSTSDD ASRLEAGGET VPERNKSNGL YFRDGKCRID
     YILVYRKSNP QTEKREVFER NIRAEGLQME KESSLINSDI IFVKLHAPWE VLGRYAEQMN
     VRMPFRRKIY YLPRRYKFMS RIDKQISRFR RWLPKKPMRL DKETLPDLEE NDCYTAPFSQ
     QRIHHFIIHN KETFFNNATR SRIVHHILQR IKYEEGKNKI GLNRLLTNGS YEAAFPLHEG
     SYRSKNSIRT HGAENHRHLL YECWASWGVW YKYQPLDLVR RYFGEKIGLY FAWLGWYTGM
     LFPAAFIGLF VFLYGVTTLD HSQVSKEVCQ ATDIIMCPVC DKYCPFMRLS DSCVYAKVTH
     LFDNGATVFF AVFMAVWATV FLEFWKRRRA VIAYDWDLID WEEEEEEIRP QFEAKYSKKE
     RMNPISGKPE PYQAFTDKCS RLIVSASGIF FMICVVIAAV FGIVIYRVVT VSTFAAFKWA
     LIRNNSQVAT TGTAVCINFC IIMLLNVLYE KVALLLTNLE QPRTESEWEN SFTLKMFLFQ
     FVNLNSSTFY IAFFLGRFTG HPGAYLRLIN RWRLEECHPS GCLIDLCMQM GIIMVLKQTW
     NNFMELGYPL IQNWWTRRKV RQEHGPERKI SFPQWEKDYN LQPMNAYGLF DEYLEMILQF
     GFTTIFVAAF PLAPLLALLN NIIEIRLDAY KFVTQWRRPL ASRAKDIGIW YGILEGIGIL
     SVITNAFVIA ITSDFIPRLV YAYKYGPCAG QGEAGQKCMV GYVNASLSVF RISDFENRSE
     PESDGSEFSG TPLKYCRYRD YRDPPHSLVP YGYTLQFWHV LAARLAFIIV FEHLVFCIKH
     LISYLIPDLP KDLRDRMRRE KYLIQEMMYE AELERLQKER KERKKNGKAH HNEWP
//
